• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Intra-arterial tenecteplase has limited use after successful endovascular recanalisation of acute posterior circulation arterial occlusion

bySimon PanandAlex Chan
January 22, 2025
in Emergency, Hematology, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In patients with acute ischemic stroke due to acute intracranial occlusions of the posterior circulation, the use of intra-arterial tenecteplase after successful endovascular recanalisation was not associated with a statistically significant reduction in combined disability and mortality at 90 days. 

Evidence Rating Level: 1 (Excellent)

Patients with occlusions of the posterior circulation suffering from acute ischemic stroke have higher rates of death or disability compared to patients with occlusions of the anterior circulation. While endovascular thrombectomy is an established management option for patients with basilar artery occlusion, patients who receive successful endovascular thrombectomy still experience low rates of positive outcomes, necessitating the need for advancements in trteatment. This randomized controlled trial therefore sought to investigate the efficacy of administering intra-arterial tenecteplase following successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion. 208 participants (mean[SD] age, 66.0[11.1] years) from 31 centres across China were randomized to receive either intra-arterial tenecteplase or standard care with successful endovascular recanalisation only. The primary outcome was the proportion of patients that were free from disability as defined by a modified Rankin scale score of 0 or 1. Overall, the proportion of patients with a modified Rankin scale score of 0 or 1 at 90 days was not significantly different between the tenecteplase and control groups (34.6% and 26.0%, respectively; adjusted risk ratio 1.36, 95% confidence interval (CI) 0.92 to 2.02; P=0.12). The 90 day mortality was similar between groups (27.9% v 26.9%; adjusted risk ratio 1.13, 95% CI 0.73 to 1.74). This study showed that the use of intra-arterial tenecteplase following successful endovascular recanalisation in patients suffering from acute posterior circulation arterial occlusion was not associated with a statistically significant reduction in disability and mortality at 90 days. 

Click to read the study in BMJ

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke

Transcranial ultrasound stimulation may modulate acute heat pain perception

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

Tags: evthematologyneurologystroketenectaplasethrombolysisthrombosis
Previous Post

Semaglutide may aid tobacco cessation in patients with comorbid diabetes

Next Post

#VisualAbstract Early Oral Anticoagulation is Non-inferior to Delayed Treatment in Patients with Ischemic Stroke and Atrial Fibrillation

RelatedReports

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke

April 24, 2026
Brain lesions on MRI linked with subsequent increased stroke risk
Imaging and Intervention

Transcranial ultrasound stimulation may modulate acute heat pain perception

April 20, 2026
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Next Post
#VisualAbstract Early Oral Anticoagulation is Non-inferior to Delayed Treatment in Patients with Ischemic Stroke and Atrial Fibrillation

#VisualAbstract Early Oral Anticoagulation is Non-inferior to Delayed Treatment in Patients with Ischemic Stroke and Atrial Fibrillation

#VisualAbstract: C-reactive Protein Testing in Primary Care Reduces Antibiotic Use in Children with Acute Respiratory Tract Infections

#VisualAbstract: C-reactive Protein Testing in Primary Care Reduces Antibiotic Use in Children with Acute Respiratory Tract Infections

Couple-based intervention may be more effective in the management of type 2 diabetes in adults

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ambient artificial intelligence scribes reduce clinician documentation time by 16 minutes per encounter
  • Resuscitative endovascular balloon occlusion of the aorta may not improve outcomes in adults with non-traumatic out-of-hospital cardiac arrest
  • Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.